Analyst Ratings for Molycorp (MCP)
MCP Rating Summary
MCP Price Target Summary
- Highest: $50.00 (Oracle Investment Research)
- Lowest: $6.00 (JPMorgan)
- Average: $16.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$16.50 (+128.5%)
Avg. $ Target:
$16.50 (+128.5%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/2/2013 | DA Davidson | New Coverage | Buy (N/A) |
7.00 (N/A) |
4.91 | 7.22 | 47.05% | Details |
| 3/15/2013 | Piper Jaffray | New Coverage | Neutral (N/A) |
8.00 (N/A) |
5.99 | 7.22 | 20.53% | Details |
| 2/7/2013 | JPMorgan | Upgrade | Neutral (Underweight) |
6.00 (5.00) |
7.57 | 7.22 | -4.62% | Details |
| 1/28/2013 | Byron Capital Markets | Upgrade | Buy (Hold) |
15.00 (N/A) |
8.00 | 7.22 | -9.75% | Details |
| 1/23/2013 | Dahlman Rose | Downgrade | Hold (Buy) |
N/A (N/A) |
8.83 | 7.22 | -18.23% | Details |
| 12/17/2012 | Goldman Sachs » Updated 5/10/2013 |
New Coverage | Neutral (N/A) |
6.00 (N/A) |
10.05 | 7.22 | -28.16% | Details |
| 12/13/2012 | Baird | New Coverage | Neutral (N/A) |
10.00 (N/A) |
10.99 | 7.22 | -34.3% | Details |
| 11/13/2012 | Morgan Stanley | Downgrade | Equalweight (Overweight) |
N/A (N/A) |
7.17 | 7.22 | 0.7% | Details |
| 8/29/2012 | Gabelli | Upgrade | Buy (Hold) |
N/A (N/A) |
10.75 | 7.22 | -32.84% | Details |
| 8/17/2012 | Oracle Investment Research » Updated 3/14/2013 |
Upgrade | Strong Buy (Buy) |
50.00 (N/A) |
9.85 | 7.22 | -26.7% | Details |
| 12/9/2011 | ThinkEquity | New Coverage | Hold (N/A) |
30.00 (N/A) |
28.90 | 7.22 | -75.02% | Details |
| 3/7/2011 | CIBC | New Coverage | Sector Outperform (N/A) |
N/A (N/A) |
49.26 | 7.22 | -85.34% | Details |
| 9/8/2010 | Stifel Nicolaus | New Coverage | Hold (N/A) |
N/A (N/A) |
22.00 | 7.22 | -67.18% | Details |
